| 5.23 -0.05 (-0.95%) | 06-12 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.78  |
1-year : | 7.67 |
| Resists | First : | 5.8 |
Second : | 6.57 |
| Pivot price | 5.11 |
|||
| Supports | First : | 4.57 | Second : | 3.8 |
| MAs | MA(5) : | 5.14 |
MA(20) : | 5.08 |
| MA(100) : | 7.11 |
MA(250) : | 12.24 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 52.1 |
D(3) : | 46.4 |
| RSI | RSI(14): 46.1 |
|||
| 52-week | High : | 22.25 | Low : | 4.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ OPRX ] has closed below upper band by 33.0%. Bollinger Bands are 69.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.37 - 5.4 | 5.4 - 5.42 |
| Low: | 5.1 - 5.13 | 5.13 - 5.15 |
| Close: | 5.19 - 5.23 | 5.23 - 5.27 |
OptimizeRx Corporation is a digital health technology firm delivering a broad spectrum of solutions to life sciences organizations, healthcare providers, and patients. Its core offerings encompass financial messaging and a virtual patient support hub, enabling healthcare providers to seamlessly access sample vouchers, co-pay assistance, and other patient support resources directly within their electronic medical records (EMR) or e-prescribing platforms. The company also facilitates brand awareness and therapeutic communication through various messaging services, including targeted ads and unbranded educational content. Additionally, OptimizeRx consults with pharmaceutical manufacturers, guiding them in devising and executing effective eRx media strategies, which involves drug file integration, sales force education, and comprehensive strategy development for product promotion. It operates a cloud-based Mobile Health Messenger platform, offering interactive health messaging to bolster medication adherence and improve care coordination. Furthermore, a HIPAA-compliant automated mobile messaging platform empowers pharmaceutical companies and associated entities to directly connect with patients, fostering better regimen compliance. Patient-centric programs provide essential treatment and affordability details, alongside lifestyle and condition trackers, internet device integration, and tools for forms and surveys. For healthcare professionals, the company offers an evidence-based physician engagement solution that leverages real-world data. This tool helps identify patients suitable for particular therapies, raises awareness of patient access routes, and detects early signs of non-adherence within patient groups. Another key offering is a therapy initiation workflow designed to expedite patient access to treatments, especially those requiring extensive medical documentation from healthcare providers before pharmacists can dispense prescribed medications. Established in 2006, OptimizeRx is headquartered in Rochester, Michigan.
Fri, 12 Jun 2026
OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen - Stock Titan
Thu, 11 Jun 2026
OPRX SEC Filings - Optimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Wed, 10 Jun 2026
How Optimizerx Corporation (OPRX) Affects Rotational Strategy Timing - Stock Traders Daily
Wed, 10 Jun 2026
OptimizeRx (OPRX) grants 34,517 restricted stock units to director - Stock Titan
Fri, 05 Jun 2026
OptimizeRx (NASDAQ: OPRX) details CCO exit, $380K salary continuation - Stock Titan
Mon, 01 Jun 2026
Number of shareholders of OptimizeRx Corporation – NASDAQ:OPRX - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 19 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 11.8 (%) |
| Held by Institutions | 76.4 (%) |
| Shares Short | 2,010 (K) |
| Shares Short P.Month | 2,160 (K) |
| EPS | 0.36 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.84 |
| Profit Margin | 6.3 % |
| Operating Margin | 2 % |
| Return on Assets (ttm) | 5.4 % |
| Return on Equity (ttm) | 5.5 % |
| Qtrly Rev. Growth | -9.5 % |
| Gross Profit (p.s.) | 4 |
| Sales Per Share | 5.71 |
| EBITDA (p.s.) | 1 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 14 (M) |
| Levered Free Cash Flow | 11 (M) |
| PE Ratio | 14.52 |
| PEG Ratio | 1.6 |
| Price to Book value | 0.76 |
| Price to Sales | 0.91 |
| Price to Cash Flow | 6.82 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|